Cargando…
Universal or targeted approach to prevent the transmission of extended-spectrum beta-lactamase-producing Enterobacteriaceae in intensive care units: a cost-effectiveness analysis
OBJECTIVE: Several control strategies have been used to limit the transmission of multidrug-resistant organisms in hospitals. However, their implementation is expensive and effectiveness of interventions for the control of extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) sprea...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722099/ https://www.ncbi.nlm.nih.gov/pubmed/29102989 http://dx.doi.org/10.1136/bmjopen-2017-017402 |
_version_ | 1783284948413710336 |
---|---|
author | Kardaś-Słoma, Lidia Lucet, Jean-Christophe Perozziello, Anne Pelat, Camille Birgand, Gabriel Ruppé, Etienne Boëlle, Pierre-Yves Andremont, Antoine Yazdanpanah, Yazdan |
author_facet | Kardaś-Słoma, Lidia Lucet, Jean-Christophe Perozziello, Anne Pelat, Camille Birgand, Gabriel Ruppé, Etienne Boëlle, Pierre-Yves Andremont, Antoine Yazdanpanah, Yazdan |
author_sort | Kardaś-Słoma, Lidia |
collection | PubMed |
description | OBJECTIVE: Several control strategies have been used to limit the transmission of multidrug-resistant organisms in hospitals. However, their implementation is expensive and effectiveness of interventions for the control of extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) spread is controversial. Here, we aim to assess the cost-effectiveness of hospital-based strategies to prevent ESBL-PE transmission and infections. DESIGN: Cost-effectiveness analysis based on dynamic, stochastic transmission model over a 1-year time horizon. PATIENTS AND SETTING: Patients hospitalised in a hypothetical 10-bed intensive care unit (ICU) in a high-income country. INTERVENTIONS: Base case scenario compared with (1) universal strategies (eg, improvement of hand hygiene (HH) among healthcare workers, antibiotic stewardship), (2) targeted strategies (eg, screening of patient for ESBL-PE at ICU admission and contact precautions or cohorting of carriers) and (3) mixed strategies (eg, targeted approaches combined with antibiotic stewardship). MAIN OUTCOMES AND MEASURES: Cases of ESBL-PE transmission, infections, cost of intervention, cost of infections, incremental cost per infection avoided. RESULTS: In the base case scenario, 15 transmissions and five infections due to ESBL-PE occurred per 100 ICU admissions, representing a mean cost of €94 792. All control strategies improved health outcomes and reduced costs associated with ESBL-PE infections. The overall costs (cost of intervention and infections) were the lowest for HH compliance improvement from 55%/60% before/after contact with a patient to 80%/80%. CONCLUSIONS: Improved compliance with HH was the most cost-saving strategy to prevent the transmission of ESBL-PE. Antibiotic stewardship was not cost-effective. However, adding antibiotic restriction strategy to HH or screening and cohorting strategies slightly improved their effectiveness and may be worthy of consideration by decision-makers. |
format | Online Article Text |
id | pubmed-5722099 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-57220992018-01-03 Universal or targeted approach to prevent the transmission of extended-spectrum beta-lactamase-producing Enterobacteriaceae in intensive care units: a cost-effectiveness analysis Kardaś-Słoma, Lidia Lucet, Jean-Christophe Perozziello, Anne Pelat, Camille Birgand, Gabriel Ruppé, Etienne Boëlle, Pierre-Yves Andremont, Antoine Yazdanpanah, Yazdan BMJ Open Infectious Diseases OBJECTIVE: Several control strategies have been used to limit the transmission of multidrug-resistant organisms in hospitals. However, their implementation is expensive and effectiveness of interventions for the control of extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) spread is controversial. Here, we aim to assess the cost-effectiveness of hospital-based strategies to prevent ESBL-PE transmission and infections. DESIGN: Cost-effectiveness analysis based on dynamic, stochastic transmission model over a 1-year time horizon. PATIENTS AND SETTING: Patients hospitalised in a hypothetical 10-bed intensive care unit (ICU) in a high-income country. INTERVENTIONS: Base case scenario compared with (1) universal strategies (eg, improvement of hand hygiene (HH) among healthcare workers, antibiotic stewardship), (2) targeted strategies (eg, screening of patient for ESBL-PE at ICU admission and contact precautions or cohorting of carriers) and (3) mixed strategies (eg, targeted approaches combined with antibiotic stewardship). MAIN OUTCOMES AND MEASURES: Cases of ESBL-PE transmission, infections, cost of intervention, cost of infections, incremental cost per infection avoided. RESULTS: In the base case scenario, 15 transmissions and five infections due to ESBL-PE occurred per 100 ICU admissions, representing a mean cost of €94 792. All control strategies improved health outcomes and reduced costs associated with ESBL-PE infections. The overall costs (cost of intervention and infections) were the lowest for HH compliance improvement from 55%/60% before/after contact with a patient to 80%/80%. CONCLUSIONS: Improved compliance with HH was the most cost-saving strategy to prevent the transmission of ESBL-PE. Antibiotic stewardship was not cost-effective. However, adding antibiotic restriction strategy to HH or screening and cohorting strategies slightly improved their effectiveness and may be worthy of consideration by decision-makers. BMJ Publishing Group 2017-11-03 /pmc/articles/PMC5722099/ /pubmed/29102989 http://dx.doi.org/10.1136/bmjopen-2017-017402 Text en © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
spellingShingle | Infectious Diseases Kardaś-Słoma, Lidia Lucet, Jean-Christophe Perozziello, Anne Pelat, Camille Birgand, Gabriel Ruppé, Etienne Boëlle, Pierre-Yves Andremont, Antoine Yazdanpanah, Yazdan Universal or targeted approach to prevent the transmission of extended-spectrum beta-lactamase-producing Enterobacteriaceae in intensive care units: a cost-effectiveness analysis |
title | Universal or targeted approach to prevent the transmission of extended-spectrum beta-lactamase-producing Enterobacteriaceae in intensive care units: a cost-effectiveness analysis |
title_full | Universal or targeted approach to prevent the transmission of extended-spectrum beta-lactamase-producing Enterobacteriaceae in intensive care units: a cost-effectiveness analysis |
title_fullStr | Universal or targeted approach to prevent the transmission of extended-spectrum beta-lactamase-producing Enterobacteriaceae in intensive care units: a cost-effectiveness analysis |
title_full_unstemmed | Universal or targeted approach to prevent the transmission of extended-spectrum beta-lactamase-producing Enterobacteriaceae in intensive care units: a cost-effectiveness analysis |
title_short | Universal or targeted approach to prevent the transmission of extended-spectrum beta-lactamase-producing Enterobacteriaceae in intensive care units: a cost-effectiveness analysis |
title_sort | universal or targeted approach to prevent the transmission of extended-spectrum beta-lactamase-producing enterobacteriaceae in intensive care units: a cost-effectiveness analysis |
topic | Infectious Diseases |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722099/ https://www.ncbi.nlm.nih.gov/pubmed/29102989 http://dx.doi.org/10.1136/bmjopen-2017-017402 |
work_keys_str_mv | AT kardassłomalidia universalortargetedapproachtopreventthetransmissionofextendedspectrumbetalactamaseproducingenterobacteriaceaeinintensivecareunitsacosteffectivenessanalysis AT lucetjeanchristophe universalortargetedapproachtopreventthetransmissionofextendedspectrumbetalactamaseproducingenterobacteriaceaeinintensivecareunitsacosteffectivenessanalysis AT perozzielloanne universalortargetedapproachtopreventthetransmissionofextendedspectrumbetalactamaseproducingenterobacteriaceaeinintensivecareunitsacosteffectivenessanalysis AT pelatcamille universalortargetedapproachtopreventthetransmissionofextendedspectrumbetalactamaseproducingenterobacteriaceaeinintensivecareunitsacosteffectivenessanalysis AT birgandgabriel universalortargetedapproachtopreventthetransmissionofextendedspectrumbetalactamaseproducingenterobacteriaceaeinintensivecareunitsacosteffectivenessanalysis AT ruppeetienne universalortargetedapproachtopreventthetransmissionofextendedspectrumbetalactamaseproducingenterobacteriaceaeinintensivecareunitsacosteffectivenessanalysis AT boellepierreyves universalortargetedapproachtopreventthetransmissionofextendedspectrumbetalactamaseproducingenterobacteriaceaeinintensivecareunitsacosteffectivenessanalysis AT andremontantoine universalortargetedapproachtopreventthetransmissionofextendedspectrumbetalactamaseproducingenterobacteriaceaeinintensivecareunitsacosteffectivenessanalysis AT yazdanpanahyazdan universalortargetedapproachtopreventthetransmissionofextendedspectrumbetalactamaseproducingenterobacteriaceaeinintensivecareunitsacosteffectivenessanalysis |